{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:45:50Z","timestamp":1792683950298,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rpth.2026.106943","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:17:02Z","timestamp":1788448622000},"page":"106943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of antithrombotic therapy in hereditary hemorrhagic telangiectasia: results from a prospective cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Luigi","family":"Di Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Feliciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Funaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Barberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Talerico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5224-2931","authenticated-orcid":false,"given":"Roberto","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106943_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/hematology.2021000281","article-title":"Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management","volume":"2021","author":"Hammill","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2026.106943_bib2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.2023021765","article-title":"How I treat bleeding in hereditary hemorrhagic telangiectasia","volume":"144","author":"Al-Samkari","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106943_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/GIM.0b013e3182136d32","article-title":"Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis","volume":"13","author":"McDonald","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.rpth.2026.106943_bib4","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.jtha.2025.12.025","article-title":"Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases","volume":"24","author":"Gaetani","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106943_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106943_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/hematology.2025000698","article-title":"What\u2019s new in hereditary hemorrhagic telangiectasia?","volume":"2025","author":"Kasthuri","year":"2025","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2026.106943_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.12998\/wjcc.v3.i4.330","article-title":"Bleeding and clotting in hereditary hemorrhagic telangiectasia","volume":"3","author":"Dittus","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.rpth.2026.106943_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH07-01-0064","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106943_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","article-title":"Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia","volume":"67","author":"Livesey","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rpth.2026.106943_bib10","article-title":"Elevated FVIII levels in hereditary hemorrhagic telangiectasia: implications for clinical management","volume":"9","author":"J\u00f8rgensen","year":"2023","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.rpth.2026.106943_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11239-025-03238-4","article-title":"Prospective evidence of increased venous thromboembolism in hereditary hemorrhagic telangiectasia","volume":"59","author":"Gaetani","year":"2026","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2026.106943_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106943_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rpth.2026.106943_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-019-1172-8","article-title":"Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia: findings from the RIETE registry","volume":"14","author":"Riera-Mestre","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rpth.2026.106943_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtha.2022.09.003","article-title":"Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia","volume":"21","author":"Virk","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106943_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2023.07.001","article-title":"Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: a large French cohort study (RETROPLACOTEL)","volume":"229","author":"Grobost","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106943_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.thromres.2023.04.017","article-title":"Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: a scoping review","volume":"226","author":"Zhang","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106943_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-019-1278-z","article-title":"Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group","volume":"14","author":"Gaetani","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rpth.2026.106943_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.rpth.2026.106943_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the ISTH. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106943_bib21","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant nonmajor bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926036010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926036010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:39Z","timestamp":1792682799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926036010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2475037926036010"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106943","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of antithrombotic therapy in hereditary hemorrhagic telangiectasia: results from a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106943"}}